Yeong An Sheu, MD
Gastroenterology · Burbank
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Providence Saint Joseph Medical Ctr. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sheu’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A72217 · Current
Licensed to practise in California · since 2000 · expires 2027-11-30 · National Taiwan University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Saint Joseph Medical CtrBurbank, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.302, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Saint Joseph Medical Ctr
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.302 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.22 to 2.03) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.95 (0.65 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.49 (127.09 to 219.89) · 79 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 246 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 508 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 762 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 405 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,463 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 9,525 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.42) · 9,594 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.44 (0.5 to 4.38) · 1,747 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.94 (0.29 to 3.59) · 501 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.69 to 3.63) · 1,665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.32 (3.85 to 18.79) · 512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.39 (3.65 to 11.13) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.03) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.22 (0 to 0.75) · 8,013 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 100 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.533 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.247 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.227 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 278 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 610 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 14.7 · 254 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 42.8 · 640 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 40.4 · 825 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.3 to 6.8) · 211 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (10.6 to 17.3) · 211 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.8 to 16.9) · 463 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 508 cases | No different | Jan 2024 – Dec 2024 |
What patients said (360 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$23,575
Medicare paid this office $23,575 for 101 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 62 | $7,483 | $121 |
| Return visit (30+ min) | 51 | $6,901 | $92 |
| Biopsy of large bowel using a flexible endoscope | 24 | $2,887 | $115 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,825 | $83 |
Procedures Medicare counted
| Colonoscopy | 30 | More than 54% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 13 | More than 45% of doctors who do this |
Who their Medicare patients are
101 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 18% · Women 59% · Also on Medicaid 83% · Health risk score 1.38. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 50% · Coronary heart disease 32% · Heart failure 25% · Depression 25% · Chronic kidney disease 18% · COPD 15% · Cancer 12% · Atrial fibrillation 12%.
The office billed $127,575, Medicare allowed $32,096 and paid $23,575; for 219 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 101 | 219 | 74 | 1.38 | $127,575 | $23,575 |
| 2023 | 93 | 238 | 75 | 1.31 | $143,489 | $25,996 |
| 2022 | 96 | 185 | 74 | 1.45 | $69,880 | $20,185 |
| 2021 | 145 | 349 | 74 | 1.75 | $155,888 | $40,106 |
| 2020 | 94 | 237 | 74 | 1.63 | $100,385 | $21,026 |
| 2019 | 155 | 462 | 74 | 2.30 | $222,000 | $44,532 |
| 2018 | 170 | 582 | 76 | 2.19 | $236,835 | $49,650 |
| 2017 | 201 | 656 | 75 | 2.45 | $229,735 | $52,954 |
| 2016 | 309 | 1,291 | 76 | 2.72 | $462,881 | $112,865 |
| 2015 | 330 | 1,268 | 74 | 2.83 | $467,875 | $115,624 |
| 2014 | 379 | 1,642 | 76 | 2.69 | $509,790 | $142,339 |
| 2013 | 621 | 2,588 | 76 | 2.74 | $675,710 | $204,045 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 56 | $8,750 | $97 |
| New patient visit (45+ min) | 36 | $4,399 | $122 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $2,783 | $82 |
| Biopsy of large bowel using a flexible endoscope | 24 | $2,550 | $106 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $2,530 | $181 |
| New patient visit (60+ min) | 12 | $2,006 | $167 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,841 | $153 |
2022: 3 services
| Return visit (30+ min) | 45 | $7,522 | $96 |
| New patient visit (45+ min) | 48 | $5,656 | $118 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,179 | $91 |
2021: 7 services
| Return visit (30+ min) | 56 | $9,098 | $111 |
| New patient visit (45+ min) | 60 | $7,872 | $131 |
| Short return visit (20+ min) | 33 | $3,223 | $75 |
| Biopsy of large bowel using a flexible endoscope | 24 | $2,737 | $114 |
| New patient visit (60+ min) | 13 | $2,480 | $191 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,212 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,352 | $61 |
2020: 6 services
| Short return visit (20+ min) | 44 | $3,305 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,137 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $3,113 | $62 |
| Biopsy of large bowel using a flexible endoscope | 20 | $2,716 | $136 |
| New patient visit (30+ min) | 34 | $2,709 | $80 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,382 | $69 |
2019: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,065 | $165 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $6,807 | $59 |
| Short return visit (20+ min) | 60 | $6,396 | $61 |
| New patient visit (30+ min) | 40 | $3,497 | $87 |
| Biopsy of large bowel using a flexible endoscope | 26 | $3,003 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,391 | $85 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,445 | $90 |
2018: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $10,724 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,115 | $162 |
| Short return visit (20+ min) | 62 | $5,908 | $58 |
| New patient visit (30+ min) | 48 | $3,984 | $83 |
| Biopsy of large bowel using a flexible endoscope | 29 | $3,092 | $107 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,454 | $144 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,311 | $210 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $1,994 | $71 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $866 | $72 |
| Injection beneath lining of large bowel using a flexible endoscope | 12 | $315 | $26 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $14,157 | $57 |
| Short return visit (20+ min) | 81 | $6,799 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,578 | $160 |
| New patient visit (30+ min) | 50 | $4,286 | $86 |
| Biopsy of large bowel using a flexible endoscope | 22 | $3,321 | $151 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $3,256 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,164 | $108 |
| Critical care, first 30-74 minutes | 11 | $1,931 | $176 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,011 | $92 |
2016: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 160 | $38,005 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 121 | $21,764 | $165 |
| Short return visit (20+ min) | 81 | $8,343 | $58 |
| Biopsy of large bowel using a flexible endoscope | 32 | $4,626 | $145 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $4,401 | $90 |
| Critical care, first 30-74 minutes | 23 | $4,163 | $181 |
| New patient visit (30+ min) | 41 | $3,466 | $85 |
| Insertion of stomach tube using a flexible endoscope | 17 | $3,126 | $174 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,087 | $220 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,307 | $144 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,116 | $111 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,955 | $89 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $957 | $87 |
2015: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 177 | $34,946 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $19,352 | $168 |
| Biopsy of large bowel using a flexible endoscope | 48 | $9,038 | $181 |
| Short return visit (20+ min) | 80 | $8,229 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 53 | $6,239 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 53 | $4,459 | $81 |
| Critical care, first 30-74 minutes | 23 | $4,245 | $185 |
| New patient visit (30+ min) | 45 | $3,825 | $85 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,601 | $257 |
| Insertion of stomach tube using a flexible endoscope | 19 | $3,400 | $179 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,358 | $181 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,685 | $99 |
2014: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 199 | $44,448 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 167 | $21,639 | $114 |
| Short return visit (20+ min) | 99 | $11,900 | $58 |
| Critical care, first 30-74 minutes | 38 | $8,357 | $186 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 23 | $8,319 | $74 |
| Biopsy of large bowel using a flexible endoscope | 39 | $7,295 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,282 | $170 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 56 | $5,129 | $90 |
| Insertion of stomach tube using a flexible endoscope | 22 | $4,183 | $182 |
| New patient visit (30+ min) | 46 | $4,125 | $90 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,665 | $183 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,655 | $95 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,894 | $90 |
| Return visit (30+ min) | 14 | $1,287 | $92 |
2013: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 394 | $80,833 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 326 | $39,152 | $112 |
| Short return visit (20+ min) | 118 | $15,614 | $60 |
| Critical care, first 30-74 minutes | 53 | $10,950 | $180 |
| Biopsy of large bowel using a flexible endoscope | 47 | $8,577 | $175 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 27 | $8,236 | $72 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | $6,791 | $100 |
| Insertion of stomach tube using a flexible endoscope | 22 | $4,628 | $210 |
| New patient visit (30+ min) | 49 | $4,325 | $88 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $3,385 | $178 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $3,321 | $255 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $2,896 | $76 |
| Hospital discharge day management, more than 30 minutes | 27 | $2,620 | $87 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,451 | $102 |
| Hospital discharge day management, 30 minutes or less | 41 | $2,442 | $60 |
| Return visit (30+ min) | 16 | $1,551 | $86 |
Medicaid work
$38,866 in 2024
Medicaid paid $38,866 for 433 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 161 | $22,513 |
| Return visit (30+ min) | 122 | $12,601 |
| COLONOSCOPY AND BIOPSY | 12 | $2,277 |
| TISSUE EXAM BY PATHOLOGIST | 39 | $1,350 |
| Injection, midazolam hydrochloride, per 1 mg | 13 | $65 |
| Injection, meperidine hydrochloride, per 100 mg | 12 | $60 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 74 | $0 |
| 2024 | 433 | 7 | 30 | $38,866 |
| 2023 | 789 | 10 | 40 | $54,948 |
| 2022 | 270 | 3 | 34 | $3,966 |
| 2021 | 447 | 4 | 34 | $6,843 |
| 2020 | 611 | 8 | 43 | $11,043 |
| 2019 | 1,555 | 13 | 54 | $36,051 |
| 2018 | 1,868 | 15 | 48 | $36,176 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 398 | $37,546 |
| Return visit (30+ min) | 197 | $13,606 |
| COLONOSCOPY AND BIOPSY | 25 | $2,411 |
| Upper gastrointestinal endoscopy with biopsy | 12 | $630 |
| TISSUE EXAM BY PATHOLOGIST | 14 | $624 |
| Injection, meperidine hydrochloride, per 100 mg | 13 | $66 |
| Injection, midazolam hydrochloride, per 1 mg | 13 | $65 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 34 | $0 |
| BODY MASS INDEX DOCD | 15 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 68 | $0 |
2022
| New patient visit (45+ min) | 190 | $3,332 |
| Return visit (30+ min) | 66 | $634 |
| COLONOSCOPY AND BIOPSY | 14 | $0 |
2021
| New patient visit (45+ min) | 234 | $4,085 |
| Short return visit (20+ min) | 166 | $1,297 |
| New patient visit (30+ min) | 35 | $801 |
| COLONOSCOPY AND BIOPSY | 12 | $660 |
2020
| New patient visit (30+ min) | 219 | $3,642 |
| COLONOSCOPY AND BIOPSY | 59 | $2,972 |
| Upper gastrointestinal endoscopy with biopsy | 27 | $1,314 |
| Service | 27 | $985 |
| Short return visit (20+ min) | 186 | $803 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $647 |
| New patient visit (45+ min) | 56 | $551 |
| Injection, midazolam hydrochloride, per 1 mg | 24 | $129 |
2019
| COLONOSCOPY AND BIOPSY | 185 | $12,090 |
| Upper gastrointestinal endoscopy with biopsy | 135 | $8,371 |
| New patient visit (30+ min) | 394 | $4,157 |
| Service | 109 | $3,677 |
| TISSUE EXAM BY PATHOLOGIST | 74 | $2,396 |
| New patient visit (45+ min) | 109 | $1,728 |
| Short return visit (20+ min) | 315 | $1,541 |
| DIAGNOSTIC COLONOSCOPY | 31 | $1,078 |
| Injection, meperidine hydrochloride, per 100 mg | 62 | $467 |
| Injection, midazolam hydrochloride, per 1 mg | 64 | $305 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 26 | $201 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 36 | $27 |
2018
| COLONOSCOPY AND BIOPSY | 207 | $9,565 |
| Service | 179 | $6,138 |
| Upper gastrointestinal endoscopy with biopsy | 108 | $5,979 |
| TISSUE EXAM BY PATHOLOGIST | 107 | $3,686 |
| New patient visit (45+ min) | 196 | $3,101 |
| New patient visit (30+ min) | 328 | $2,193 |
| DIAGNOSTIC COLONOSCOPY | 41 | $2,106 |
| Injection, meperidine hydrochloride, per 100 mg | 128 | $995 |
| Short return visit (20+ min) | 316 | $840 |
| Injection, midazolam hydrochloride, per 1 mg | 133 | $670 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 43 | $365 |
| Infusion, normal saline solution , 1000 cc | 28 | $263 |
Drugs they prescribed that Part D paid
$152,247
Pharmacies billed $152,247 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 542) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
398 generic and 144 brand-name prescriptions · $152,247 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Creon | 23 | $44,533 | $1,936 |
| Dipentum | 11 | $34,229 | $3,112 |
| Vemlidy | 12 | $19,496 | $1,625 |
| Trelegy Ellipta | 11 | $6,998 | $636 |
| Xarelto | 11 | $6,036 | $549 |
See all 20 drugs
| Creon | 23 | $44,533 | $1,936 |
| Dipentum | 11 | $34,229 | $3,112 |
| Vemlidy | 12 | $19,496 | $1,625 |
| Trelegy Ellipta | 11 | $6,998 | $636 |
| Xarelto | 11 | $6,036 | $549 |
| Mesalamine | 22 | $5,274 | $240 |
| Peg 3350-Electrolyte | 116 | $2,392 | $21 |
| Entecavir | 12 | $1,089 | $91 |
| Omeprazole | 37 | $304 | $8 |
| Gavilyte-G | 13 | $176 | $14 |
| Famotidine | 17 | $130 | $8 |
| Pantoprazole | 20 | $91 | $5 |
| Meclizine | 11 | $70 | $6 |
| Atorvastatin | 13 | $58 | $4 |
| Digoxin | 11 | $38 | $3 |
| Levothyroxine | 11 | $28 | $3 |
| Glimepiride | 11 | $13 | $1 |
| Gabapentin | 11 | $10 | $1 |
| Metformin | 15 | $8 | $1 |
| Furosemide | 11 | $6 | $1 |
Year by year
| 2024 | 542 | 181 | 0% (0) | 27% | $152,247 |
| 2023 | 528 | 189 | 0% (0) | None | $142,864 |
| 2022 | 461 | 124 | 0% (0) | None | $82,679 |
| 2021 | 497 | 93 | 0% (0) | 21% | $81,944 |
| 2020 | 618 | 46 | None | 12% | $58,827 |
| 2019 | 621 | 60 | None | 15% | $60,841 |
| 2018 | 811 | 61 | None | 18% | $46,108 |
| 2017 | 1,053 | 64 | None | None | $158,703 |
| 2016 | 1,439 | 62 | 2% (24) | None | $105,611 |
| 2015 | 1,772 | 69 | 2% (27) | None | $138,511 |
| 2014 | 2,356 | 86 | 4% (91) | 26% | $158,072 |
| 2013 | 2,081 | 140 | 4% (75) | 21% | $116,448 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Creon | 22 | $44,523 | $2,024 |
| Trelegy Ellipta | 11 | $7,588 | $690 |
| Xarelto | 11 | $6,447 | $586 |
| Peg 3350-Electrolyte | 126 | $2,847 | $23 |
| Tolterodine Tartrate Er | 11 | $2,652 | $241 |
| Entecavir | 13 | $1,344 | $103 |
| Omeprazole | 44 | $535 | $12 |
| Famotidine | 17 | $332 | $20 |
| Digoxin | 12 | $313 | $26 |
| Gavilyte-G | 13 | $263 | $20 |
| Pantoprazole | 17 | $194 | $11 |
| Atorvastatin | 11 | $153 | $14 |
| Gabapentin | 11 | $142 | $13 |
| Levothyroxine | 11 | $138 | $13 |
| Glimepiride | 11 | $134 | $12 |
| Metformin | 16 | $116 | $7 |
| Furosemide | 11 | $45 | $4 |
2022: 18 drugs
| Creon | 13 | $26,242 | $2,019 |
| Pentasa | 11 | $18,259 | $1,660 |
| Trelegy Ellipta | 12 | $8,040 | $670 |
| Xarelto | 12 | $6,675 | $556 |
| Tolterodine Tartrate Er | 12 | $2,824 | $235 |
| Cholestyramine | 13 | $2,524 | $194 |
| Peg 3350-Electrolyte | 48 | $1,154 | $24 |
| Omeprazole | 69 | $483 | $7 |
| Pantoprazole | 27 | $241 | $9 |
| Levothyroxine | 12 | $238 | $20 |
| Famotidine | 19 | $165 | $9 |
| Gavilyte-G | 11 | $157 | $14 |
| Amoxicillin | 12 | $143 | $12 |
| Glimepiride | 12 | $124 | $10 |
| Gabapentin | 12 | $65 | $5 |
| Atorvastatin | 12 | $64 | $5 |
| Furosemide | 12 | $52 | $4 |
| Metformin | 21 | $39 | $2 |
2021: 18 drugs
| Creon | 11 | $22,458 | $2,042 |
| Pentasa | 11 | $15,597 | $1,418 |
| Trelegy Ellipta | 12 | $7,633 | $636 |
| Xarelto | 12 | $6,223 | $519 |
| Suprep | 24 | $2,568 | $107 |
| Tolterodine Tartrate Er | 12 | $704 | $59 |
| Omeprazole | 53 | $496 | $9 |
| Pantoprazole | 31 | $221 | $7 |
| Famotidine | 21 | $158 | $8 |
| Levothyroxine | 12 | $155 | $13 |
| Simvastatin | 22 | $150 | $7 |
| Meclizine | 13 | $122 | $9 |
| Amlodipine Besylate | 19 | $97 | $5 |
| Metformin | 23 | $74 | $3 |
| Furosemide | 17 | $44 | $3 |
| Atorvastatin | 12 | $31 | $3 |
| Glimepiride | 12 | $29 | $2 |
| Gabapentin | 12 | $26 | $2 |
2020: 20 drugs
| Xarelto | 12 | $5,839 | $487 |
| Potassium Chloride | 23 | $3,418 | $149 |
| Hydralazine | 38 | $682 | $18 |
| Tolterodine Tartrate Er | 12 | $667 | $56 |
| Glycopyrrolate | 35 | $664 | $19 |
| Levetiracetam | 19 | $567 | $30 |
| Fluocinonide | 11 | $411 | $37 |
| Doxazosin Mesylate | 27 | $381 | $14 |
| Clonidine | 35 | $371 | $11 |
| Omeprazole | 42 | $365 | $9 |
| Furosemide | 48 | $173 | $4 |
| Levothyroxine | 13 | $169 | $13 |
| Meclizine | 13 | $145 | $11 |
| Pantoprazole | 25 | $129 | $5 |
| Amlodipine Besylate | 35 | $116 | $3 |
| Simvastatin | 20 | $97 | $5 |
| Atorvastatin | 12 | $40 | $3 |
| Metformin | 24 | $34 | $1 |
| Glimepiride | 12 | $31 | $3 |
| Gabapentin | 12 | $30 | $3 |
2019: 24 drugs
| Pentasa | 12 | $17,270 | $1,439 |
| Xarelto | 11 | $4,943 | $449 |
| Potassium Chloride | 11 | $1,790 | $163 |
| Tolterodine Tartrate Er | 12 | $890 | $74 |
| Fluocinonide | 13 | $659 | $51 |
| Levetiracetam | 15 | $569 | $38 |
| Hydralazine | 29 | $495 | $17 |
| Glycopyrrolate | 19 | $361 | $19 |
| Sucralfate | 11 | $315 | $29 |
| Omeprazole | 39 | $276 | $7 |
| Levothyroxine | 16 | $268 | $17 |
| Pantoprazole | 33 | $252 | $8 |
| Clonidine | 23 | $224 | $10 |
| Doxazosin Mesylate | 13 | $185 | $14 |
| Memantine | 12 | $184 | $15 |
| Meclizine | 11 | $172 | $16 |
| Donepezil | 23 | $142 | $6 |
| Furosemide | 37 | $121 | $3 |
| Simvastatin | 21 | $83 | $4 |
| Amlodipine Besylate | 18 | $60 | $3 |
| Atorvastatin | 11 | $47 | $4 |
| Metformin | 23 | $43 | $2 |
| Gabapentin | 12 | $30 | $2 |
| Glimepiride | 11 | $29 | $3 |
2018: 29 drugs
| Lyrica | 15 | $10,176 | $678 |
| Nexium | 11 | $5,592 | $508 |
| Xarelto | 11 | $4,665 | $424 |
| Symbicort | 11 | $3,643 | $331 |
| Esomeprazole Magnesium | 12 | $2,393 | $199 |
| Ventolin Hfa | 15 | $1,636 | $109 |
| Fluocinonide | 14 | $1,559 | $111 |
| Tolterodine Tartrate Er | 11 | $1,500 | $136 |
| Hydralazine | 52 | $764 | $15 |
| Proctozone-Hc | 13 | $671 | $52 |
| Omeprazole | 91 | $654 | $7 |
| Sucralfate | 20 | $545 | $27 |
| Levothyroxine | 22 | $302 | $14 |
| Donepezil | 24 | $231 | $10 |
| Memantine | 12 | $223 | $19 |
| Atorvastatin | 27 | $202 | $7 |
| Amlodipine Besylate | 48 | $186 | $4 |
| Nifedipine Er | 12 | $160 | $13 |
| Pantoprazole | 31 | $131 | $4 |
| Furosemide | 40 | $111 | $3 |
| Glimepiride | 17 | $107 | $6 |
| Simvastatin | 31 | $107 | $3 |
| Clonidine | 13 | $82 | $6 |
| Potassium Chloride | 11 | $80 | $7 |
| Alprazolam | 12 | $69 | $6 |
| Gabapentin | 16 | $64 | $4 |
| Famotidine | 11 | $55 | $5 |
| Metformin | 23 | $47 | $2 |
| Terazosin | 12 | $44 | $4 |
2017: 37 drugs
| Nexium | 23 | $11,702 | $509 |
| Entecavir | 14 | $11,337 | $810 |
| Lyrica | 15 | $9,153 | $610 |
| Octreotide Acetate | 11 | $8,084 | $735 |
| Fluocinonide | 21 | $2,083 | $99 |
| Ventolin Hfa | 23 | $1,979 | $86 |
| Tolterodine Tartrate Er | 11 | $1,762 | $160 |
| Vascepa | 12 | $1,568 | $131 |
| Omega-3 Acid Ethyl Esters | 12 | $1,240 | $103 |
| Hydralazine | 47 | $859 | $18 |
| Omeprazole | 156 | $760 | $5 |
| Sucralfate | 28 | $715 | $26 |
| Gabapentin | 36 | $366 | $10 |
| Donepezil | 30 | $326 | $11 |
| Ondansetron | 11 | $315 | $29 |
| Atorvastatin | 30 | $313 | $10 |
| Baclofen | 12 | $209 | $17 |
| Levothyroxine | 16 | $194 | $12 |
| Nifedipine Er | 12 | $189 | $16 |
| Pantoprazole | 28 | $188 | $7 |
| Glimepiride | 23 | $185 | $8 |
| Metoprolol | 12 | $183 | $15 |
| Metronidazole | 13 | $163 | $13 |
| Amlodipine Besylate | 42 | $160 | $4 |
| Simvastatin | 38 | $126 | $3 |
| Clonidine | 14 | $115 | $8 |
| Valsartan | 13 | $113 | $9 |
| Metoprolol | 18 | $99 | $5 |
| Trazodone | 12 | $88 | $7 |
| Alendronate | 13 | $65 | $5 |
| Primidone | 11 | $64 | $6 |
| Metformin | 26 | $58 | $2 |
| Pramipexole Dihydrochloride | 11 | $56 | $5 |
| Alprazolam | 17 | $37 | $2 |
| Terazosin | 12 | $37 | $3 |
| Furosemide | 26 | $33 | $1 |
| Fluoxetine | 12 | $32 | $3 |
2016: 49 drugs
| Entecavir | 13 | $11,596 | $892 |
| Nexium | 23 | $11,083 | $482 |
| Octreotide Acetate | 11 | $10,505 | $955 |
| Lyrica | 11 | $5,805 | $528 |
| Advair Diskus | 12 | $5,387 | $449 |
| Fluocinonide | 30 | $3,467 | $116 |
| Lumigan | 13 | $2,068 | $159 |
| Tolterodine Tartrate Er | 12 | $1,904 | $159 |
| Vascepa | 14 | $1,690 | $121 |
| Ventolin Hfa | 15 | $1,349 | $90 |
| Omega-3 Acid Ethyl Esters | 12 | $1,063 | $89 |
| Hydralazine | 47 | $942 | $20 |
| Omeprazole | 171 | $852 | $5 |
| Donepezil | 44 | $806 | $18 |
| Bethanechol Chloride | 14 | $615 | $44 |
| Ondansetron | 11 | $597 | $54 |
| Levothyroxine | 37 | $475 | $13 |
| Atorvastatin | 42 | $421 | $10 |
| Tamsulosin | 19 | $413 | $22 |
| Valsartan | 21 | $395 | $19 |
| Hydrocodone-Acetaminophen | 17 | $335 | $20 |
| Levetiracetam | 13 | $314 | $24 |
| Gabapentin | 33 | $284 | $9 |
| Metoprolol | 22 | $277 | $13 |
| Baclofen | 13 | $224 | $17 |
| Pantoprazole | 24 | $223 | $9 |
| Glimepiride | 26 | $210 | $8 |
| Metronidazole | 13 | $193 | $15 |
| Finasteride | 14 | $192 | $14 |
| Nifedipine Er | 12 | $187 | $16 |
| Amoxicillin | 15 | $150 | $10 |
| Amlodipine Besylate | 50 | $149 | $3 |
| Hydroxyzine | 13 | $148 | $11 |
| Warfarin | 12 | $126 | $11 |
| Clonidine | 23 | $124 | $5 |
| Atenolol | 18 | $113 | $6 |
| Famotidine | 13 | $109 | $8 |
| Mirtazapine | 13 | $107 | $8 |
| Lisinopril | 15 | $106 | $7 |
| Metformin | 28 | $102 | $4 |
| Simvastatin | 40 | $100 | $3 |
| Dicyclomine | 15 | $98 | $7 |
| Metoprolol | 18 | $93 | $5 |
| Trazodone | 14 | $90 | $6 |
| Terazosin | 20 | $54 | $3 |
| Alendronate | 11 | $47 | $4 |
| Fluoxetine | 15 | $37 | $2 |
| Furosemide | 22 | $23 | $1 |
| Alprazolam | 18 | $21 | $1 |
2015: 61 drugs
| Procrit | 15 | $17,315 | $1,154 |
| Asacol Hd | 13 | $13,235 | $1,018 |
| Nexium | 20 | $8,426 | $421 |
| Lyrica | 14 | $6,415 | $458 |
| Advair Diskus | 12 | $4,826 | $402 |
| Tradjenta | 26 | $4,364 | $168 |
| Namenda Xr | 26 | $4,179 | $161 |
| Spiriva | 12 | $3,741 | $312 |
| Fluocinonide | 27 | $3,589 | $133 |
| Lumigan | 18 | $2,598 | $144 |
| Namenda | 14 | $2,356 | $168 |
| Tolterodine Tartrate Er | 12 | $2,169 | $181 |
| Proair Hfa | 25 | $1,967 | $79 |
| Vascepa | 14 | $1,525 | $109 |
| Valsartan | 20 | $1,094 | $55 |
| Omeprazole | 127 | $1,032 | $8 |
| Omega-3 Acid Ethyl Esters | 11 | $979 | $89 |
| Fenofibrate | 12 | $913 | $76 |
| Bethanechol Chloride | 19 | $825 | $43 |
| Donepezil | 44 | $795 | $18 |
| Levothyroxine | 57 | $776 | $14 |
| Atorvastatin | 50 | $754 | $15 |
| Gabapentin | 32 | $633 | $20 |
| Tamsulosin | 27 | $616 | $23 |
| Levetiracetam | 17 | $600 | $35 |
| Hydralazine | 27 | $542 | $20 |
| Oxybutynin Chloride Er | 17 | $503 | $30 |
| Lactulose | 42 | $386 | $9 |
| Hydrocodone-Acetaminophen | 19 | $360 | $19 |
| Glimepiride | 37 | $344 | $9 |
| Pravastatin | 14 | $334 | $24 |
| Metoprolol | 22 | $312 | $14 |
| Baclofen | 12 | $285 | $24 |
| Carbidopa-Levodopa | 12 | $275 | $23 |
| Amlodipine Besylate | 48 | $256 | $5 |
| Mirtazapine | 14 | $244 | $17 |
| Pantoprazole | 16 | $228 | $14 |
| Metoclopramide | 13 | $217 | $17 |
| Nifedipine Er | 11 | $216 | $20 |
| Atenolol | 39 | $211 | $5 |
| Metronidazole | 12 | $198 | $16 |
| Escitalopram | 17 | $196 | $12 |
| Finasteride | 13 | $192 | $15 |
| Simvastatin | 51 | $188 | $4 |
| Lisinopril | 24 | $165 | $7 |
| Clonidine | 32 | $157 | $5 |
| Divalproex | 14 | $149 | $11 |
| Famotidine | 11 | $118 | $11 |
| Isosorbide Mononitrate | 17 | $98 | $6 |
| Terazosin | 23 | $97 | $4 |
| Risperidone | 11 | $90 | $8 |
| Isosorbide Mononitrate Er | 11 | $86 | $8 |
| Metoprolol | 18 | $79 | $4 |
| Alprazolam | 29 | $73 | $3 |
| Metformin | 26 | $73 | $3 |
| Furosemide | 41 | $69 | $2 |
| Hydrochlorothiazide | 15 | $66 | $4 |
| Trazodone | 15 | $62 | $4 |
| Fluoxetine | 15 | $47 | $3 |
| Glipizide | 17 | $33 | $2 |
| Zolpidem | 19 | $24 | $1 |
2014: 80 drugs
| Forteo | 11 | $17,862 | $1,624 |
| Octreotide Acetate | 11 | $9,224 | $839 |
| Diovan | 38 | $7,260 | $191 |
| Lyrica | 21 | $6,706 | $319 |
| Colcrys | 22 | $5,720 | $260 |
| Santyl | 26 | $5,205 | $200 |
| Advair Diskus | 14 | $5,189 | $371 |
| Spiriva | 17 | $4,998 | $294 |
| Lidoderm | 14 | $3,734 | $267 |
| Januvia | 12 | $3,579 | $298 |
| Fluocinonide | 37 | $3,392 | $92 |
| Crestor | 22 | $3,321 | $151 |
| Effient | 12 | $3,223 | $269 |
| Enoxaparin | 22 | $2,803 | $127 |
| Lovaza | 20 | $2,351 | $118 |
| Proair Hfa | 28 | $2,032 | $73 |
| Lumigan | 16 | $2,029 | $127 |
| Namenda | 15 | $1,427 | $95 |
| Donepezil | 55 | $1,120 | $20 |
| Fenofibrate | 12 | $1,094 | $91 |
| Atorvastatin | 66 | $1,046 | $16 |
| Omeprazole | 123 | $1,004 | $8 |
| Gabapentin | 36 | $977 | $27 |
| Hydrocodone-Acetaminophen | 64 | $965 | $15 |
| Labetalol | 17 | $882 | $52 |
| Ondansetron | 11 | $882 | $80 |
| Levothyroxine | 61 | $777 | $13 |
| Levetiracetam | 25 | $692 | $28 |
| Oxybutynin Chloride Er | 14 | $618 | $44 |
| Amlodipine Besylate | 79 | $587 | $7 |
| Methotrexate | 13 | $492 | $38 |
| Nifedipine Er | 13 | $441 | $34 |
| Polyethylene Glycol 3350 | 18 | $425 | $24 |
| Hydralazine | 25 | $416 | $17 |
| Glimepiride | 37 | $408 | $11 |
| Pantoprazole | 24 | $396 | $16 |
| Olanzapine | 11 | $393 | $36 |
| Tamsulosin | 24 | $371 | $15 |
| Bethanechol Chloride | 28 | $348 | $12 |
| Levofloxacin | 13 | $337 | $26 |
| Lactulose | 26 | $335 | $13 |
| Clonidine | 53 | $331 | $6 |
| Divalproex | 22 | $321 | $15 |
| Megestrol Acetate | 11 | $318 | $29 |
| Metoprolol | 17 | $308 | $18 |
| Carvedilol | 26 | $293 | $11 |
| Simvastatin | 55 | $267 | $5 |
| Lansoprazole | 11 | $256 | $23 |
| Carbidopa-Levodopa | 13 | $248 | $19 |
| Risperidone | 14 | $241 | $17 |
| Atenolol | 45 | $225 | $5 |
| Furosemide | 77 | $224 | $3 |
| Potassium Chloride | 14 | $219 | $16 |
| Pravastatin | 13 | $215 | $17 |
| Mirtazapine | 12 | $214 | $18 |
| Finasteride | 15 | $195 | $13 |
| Metoclopramide | 13 | $186 | $14 |
| Zolpidem | 15 | $182 | $12 |
| Warfarin | 28 | $174 | $6 |
| Phenytoin Sodium Extended | 13 | $174 | $13 |
| Tramadol | 15 | $172 | $11 |
| Terazosin | 24 | $167 | $7 |
| Lisinopril | 32 | $162 | $5 |
| Prednisone | 11 | $156 | $14 |
| Ondansetron | 14 | $153 | $11 |
| Enalapril Maleate | 17 | $148 | $9 |
| Sertraline | 19 | $142 | $7 |
| Alcohol Prep Pads | 11 | $129 | $12 |
| Fluoxetine | 13 | $126 | $10 |
| Escitalopram | 14 | $126 | $9 |
| Metoprolol | 27 | $112 | $4 |
| Metformin | 26 | $101 | $4 |
| Temazepam | 15 | $98 | $7 |
| Amitriptyline | 11 | $93 | $8 |
| Isosorbide Mononitrate | 14 | $84 | $6 |
| Trazodone | 14 | $78 | $6 |
| Ibuprofen | 13 | $74 | $6 |
| Hydrochlorothiazide | 16 | $72 | $5 |
| Alendronate | 13 | $68 | $5 |
| Alprazolam | 11 | $56 | $5 |
2013: 70 drugs
| Octreotide Acetate | 13 | $11,548 | $888 |
| Colcrys | 16 | $4,460 | $279 |
| Diovan | 26 | $4,148 | $160 |
| Lyrica | 11 | $3,346 | $304 |
| Crestor | 18 | $2,917 | $162 |
| Detrol La | 11 | $2,200 | $200 |
| Lovaza | 21 | $2,189 | $104 |
| Donepezil | 55 | $2,136 | $39 |
| Enoxaparin | 11 | $2,083 | $189 |
| Divalproex Sodium Er | 16 | $1,719 | $107 |
| Omeprazole | 124 | $1,460 | $12 |
| Fenofibrate | 12 | $1,408 | $117 |
| Atorvastatin | 46 | $1,225 | $27 |
| Gabapentin | 19 | $1,164 | $61 |
| Proair Hfa | 17 | $890 | $52 |
| Fluocinonide | 26 | $865 | $33 |
| Lansoprazole | 16 | $815 | $51 |
| Megestrol Acetate | 18 | $801 | $44 |
| Hydrocodone-Acetaminophen | 55 | $659 | $12 |
| Bethanechol Chloride | 24 | $617 | $26 |
| Polyethylene Glycol 3350 | 20 | $572 | $29 |
| Levetiracetam | 19 | $564 | $30 |
| Oxybutynin Chloride Er | 12 | $553 | $46 |
| Finasteride | 17 | $536 | $32 |
| Amlodipine Besylate | 70 | $520 | $7 |
| Lactulose | 26 | $516 | $20 |
| Simvastatin | 64 | $481 | $8 |
| Ondansetron | 17 | $475 | $28 |
| Labetalol | 14 | $466 | $33 |
| Tamsulosin | 25 | $461 | $18 |
| Pantoprazole | 29 | $458 | $16 |
| Hydralazine | 25 | $445 | $18 |
| Nifedipine Er | 13 | $420 | $32 |
| Amox Tr-Potassium Clavulanate | 12 | $415 | $35 |
| Clonidine | 47 | $361 | $8 |
| Methotrexate | 13 | $361 | $28 |
| Isosorbide Dinitrate | 12 | $316 | $26 |
| Levothyroxine | 40 | $315 | $8 |
| Risperidone | 13 | $312 | $24 |
| Warfarin | 37 | $306 | $8 |
| Metoprolol | 30 | $293 | $10 |
| Metoprolol | 12 | $282 | $24 |
| Carvedilol | 25 | $267 | $11 |
| Metronidazole | 19 | $264 | $14 |
| Glimepiride | 28 | $259 | $9 |
| Carbidopa-Levodopa | 13 | $254 | $20 |
| Divalproex | 21 | $246 | $12 |
| Atenolol | 39 | $243 | $6 |
| Lisinopril | 34 | $236 | $7 |
| Pravastatin | 16 | $231 | $14 |
| Valproic Acid | 12 | $228 | $19 |
| Econazole Nitrate | 13 | $220 | $17 |
| Mirtazapine | 11 | $207 | $19 |
| Valproic Acid | 11 | $205 | $19 |
| Metoclopramide | 21 | $199 | $9 |
| Terazosin | 24 | $173 | $7 |
| Tramadol | 11 | $170 | $15 |
| Doxazosin Mesylate | 15 | $157 | $10 |
| Furosemide | 44 | $153 | $3 |
| Phenytoin Sodium Extended | 13 | $135 | $10 |
| Benztropine Mesylate | 12 | $131 | $11 |
| Metformin | 19 | $128 | $7 |
| Alendronate | 17 | $117 | $7 |
| Alcohol Prep Pads | 13 | $107 | $8 |
| Levofloxacin | 11 | $99 | $9 |
| Hydrochlorothiazide | 23 | $95 | $4 |
| Enalapril Maleate | 15 | $87 | $6 |
| Trazodone | 11 | $67 | $6 |
| Propranolol | 12 | $59 | $5 |
| Ibuprofen | 13 | $53 | $4 |
Money from drug and device companies
$28 in 2024
| 2024 | 1 | 2 | None | $28 |
| 2023 | 1 | 1 | None | $25 |
| 2022 | 1 | 1 | None | $80 |
| 2021 | 2 | 3 | None | $75 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Phathom Pharmaceuticals | Voquezna | $28 | 2 payments
|
See all 2 published payments
| Phathom Pharmaceuticals | Meals · 2024-05-08 | Voquezna | $14 |
| Phathom Pharmaceuticals | Meals · 2024-02-01 | Voquezna | $14 |
See earlier years (2023, 2022, 2021)
2023: $25
| Otsuka America Pharmaceutical | Jynarque | $25 | 1 payment
|
2022: $80
| Braintree Laboratories | Sutab | $80 | 1 payment
|
2021: $75
| AbbVie | Linzess | $48 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $27 | 1 payment
|
Professional record
- NPI
- 1700865177
- Licence
- CA A72217California A72217: Current · expires 2027-11-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A722170
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- Po Box 80940, San Marino, CA, 91118
- NPI first listed
- 2006-01-12
- NPI last updated
- 2012-09-05
This is when the NPI record was last certified, not a medical board exam.